Anti-CRLS1 monoclonal antibody

Pre-made anti-CRLS1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to CRLS1/CRLS1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0615-Ab-1/ GM-Tg-hg-IP0615-Ab-2Anti-Human CRLS1 monoclonal antibodyHuman
GM-Tg-rg-IP0615-Ab-1/ GM-Tg-rg-IP0615-Ab-2Anti-Rat CRLS1 monoclonal antibodyRat
GM-Tg-mg-IP0615-Ab-1/ GM-Tg-mg-IP0615-Ab-2Anti-Mouse CRLS1 monoclonal antibodyMouse
GM-Tg-cynog-IP0615-Ab-1/ GM-Tg-cynog-IP0615-Ab-2Anti-Cynomolgus/ Rhesus macaque CRLS1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0615-Ab-1/ GM-Tg-felg-IP0615-Ab-2Anti-Feline CRLS1 monoclonal antibodyFeline
GM-Tg-cang-IP0615-Ab-1/ GM-Tg-cang-IP0615-Ab-2Anti-Canine CRLS1 monoclonal antibodyCanine
GM-Tg-bovg-IP0615-Ab-1/ GM-Tg-bovg-IP0615-Ab-2Anti-Bovine CRLS1 monoclonal antibodyBovine
GM-Tg-equg-IP0615-Ab-1/ GM-Tg-equg-IP0615-Ab-2Anti-Equine CRLS1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0615-Ab-1/ GM-Tg-hg-IP0615-Ab-2; GM-Tg-rg-IP0615-Ab-1/ GM-Tg-rg-IP0615-Ab-2;
GM-Tg-mg-IP0615-Ab-1/ GM-Tg-mg-IP0615-Ab-2; GM-Tg-cynog-IP0615-Ab-1/ GM-Tg-cynog-IP0615-Ab-2;
GM-Tg-felg-IP0615-Ab-1/ GM-Tg-felg-IP0615-Ab-2; GM-Tg-cang-IP0615-Ab-1/ GM-Tg-cang-IP0615-Ab-2;
GM-Tg-bovg-IP0615-Ab-1/ GM-Tg-bovg-IP0615-Ab-2; GM-Tg-equg-IP0615-Ab-1/ GM-Tg-equg-IP0615-Ab-2
Products NameAnti-CRLS1 monoclonal antibody
Formatmab
Target NameCRLS1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-CRLS1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0615-Ag-1Recombinant multi-species CRLS1/ C20orf155/ CLS protein
    ORF Viral VectorvGMLP005143human CRLS1 Lentivirus particle
    ORF Viral VectorpGMLP005143human CRLS1 Lentivirus plasmid


    Target information

    Target IDGM-IP0615
    Target NameCRLS1
    Gene ID54675,66586,366196,718265,607530,101081971,512761,100065537
    Gene Symbol and Synonyms0610009I22Rik,4930557M15Rik,5730490M08Rik,C20orf155,CLS,CLS1,COSPD57,CRLS1,dJ967N21.6,GCD10,RGD1311037
    Uniprot AccessionQ9UJA2,Q5U2V5
    Uniprot Entry NameCRLS1_HUMAN,CRLS1_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000088766
    Target ClassificationN/A

    The target: CRLS1, gene name: CRLS1, also named as C20orf155, CLS, CLS1, GCD10, dJ967N21.6. This gene encodes a member of the CDP-alcohol phosphatidyltransferase class-I family of proteins. The encoded enzyme catalyzes the synthesis of cardiolipin, a phospholipid component of mitochondrial membranes that is critical for mitochondrial function. [provided by RefSeq, Apr 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.